Kyle Yang

Kyle Yang is a motivated and analytical accounting professional currently working at Gilead Sciences in Corporate Strategic Finance since 2021. Previously, Kyle served as a Senior Financial Analyst at The Janssen Pharmaceutical Companies of Johnson & Johnson from 2019 to 2021, where they contributed to projects related to COVID-19 vaccines and inventory FP&A. Prior to that, Kyle held a similar role at Johnson & Johnson from 2015 to 2019. Kyle is pursuing a Bachelor's Degree in Accounting, Finance, and Management Information Systems at Drexel University - College of Business and Administration.